Strona Badania kliniczne Nct
Clinical Trial Results:
Efficacy and safety of tafluprost 0.0015% eye drops as adjunctive therapy with timolol 0.5% eye drops. A randomised, placebo-controlled, phase III study in patients with open-angle glaucoma or ocular hypertension.
| Summary | |
EudraCT number | 2004-004974-94 |
Trial protocol | EE LV |
Global completion date | 17 Feb 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 10 Feb 2016 |
First version publication date | 01 Apr 2015 |
Other versions | |
Summary report(s) | 74460 study report synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.